Lucas Diniz da Conceição

Lucas Diniz da Conceição

Auto-generated profile, based on publicly available information

Lucas Diniz da Conceição

Department of Medical Sciences, Federal Fluminense University , 24220-900 Rio de Janeiro

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2025 in Cancer Research Communications
Verified
Journal Article
Open access
LLLuís Felipe Leite
Luís Felipe Leite
LCLucas Diniz da Conceição
Lucas Diniz da Conceição
ESErick F. Saldanha
Erick F. Saldanha
SMSamuel Menezes
Samuel Menezes
AMAndreia C. De Melo
Andreia C. De Melo
VLVLADMIR Cláudio CORDEIRO DE LIMA
VLADMIR Cláudio CORDEIRO DE LIMA
Cancer is a leading cause of death in Latin America and the Caribbean (LAC), and up-to-date estimates are essential to guide cancer policy. Using GLOBOCAN 2022 data, we analyzed cancer incidence and mortality across 32 LAC countries, calculated age-standardized rates, and assessed early-onset cancer (diagnosed at ages 15–50 years). Mortality-to-incidence ratios were used as a proxy for survival, joinpoint regression estimated annual percent change, and linear regression evaluated correlation between the Human Development Index and cancer indicators. In 2022, LAC recorded 1,551,060 new cancer cases (age-standardized incidence rate, 186.6 per 100,000) and 749,242 deaths (age-standardized mortality rate, 85.2 per 100,000). Prostate and breast cancers were the most common malignancies, whereas lung and breast cancers caused the highest mortality. Mortality declined for prostate cancer [annual percent change, −1.52; 95% confidence interval (CI), −1.80 to −1.24] and male lung cancer (−2.50; 95% CI, −2.68 to −2.33) but increased for female lung (+1.88; 95% CI, 1.71–2.05) and colorectal cancer (+2.48; 95% CI, 2.30–2.67). Human Development Index showed an inverse correlation with mortality-to-incidence ratio (P < 0.001), suggesting improved survival with higher development. Early-onset cancers represented 17% of new cases and 11% of deaths. These findings reveal a growing cancer burden and that persistent disparities in cancer epidemiology persist across LAC, highlighting the urgent need for targeted cancer control strategies and regional cancer control plans. Significance: These findings highlight the urgent need for equity-focused cancer control policies, improved early detection, and expanded access to essential cancer care in the region.

25 April 2025 in European Journal of Cancer
Verified
Journal Article
Closed access
MNMariana Macambira Noronha
Mariana Macambira Noronha
LALuiz Felipe Costa de Almeida
Luiz Felipe Costa de Almeida
ACAnelise Poluboiarinov Cappellaro
Anelise Poluboiarinov Cappellaro
LSLuís Felipe Leite Da Silva
Luís Felipe Leite Da Silva
LCLucas Diniz da Conceição
Lucas Diniz da Conceição
Renata D'Alpino PeixotoRenata D'Alpino Peixoto
Renata D'Alpino Peixoto

1 April 2025 in JCO Global Oncology
Verified
Journal Article
Closed access
LCLucas Diniz da Conceição
Lucas Diniz da Conceição
LSLuís Felipe Leite da Silva
Luís Felipe Leite da Silva
MNMariana Macambira Noronha
Mariana Macambira Noronha
MBMarcos Belotto
Marcos Belotto
TMThais Baccili Cury Megid
Thais Baccili Cury Megid
Renata D'Alpino PeixotoRenata D'Alpino Peixoto
Renata D'Alpino Peixoto
PURPOSE: Early-onset pancreatic cancer (EOPC) is an emerging global health concern, defined as pancreatic cancer (PC) diagnosed before age 50 years. This study aims to evaluate global trends in EOPC incidence, mortality, and associated risk factors, with projections of future burden through 2040. METHODS: A population-based analysis was conducted using the Global Burden of Diseases, Injuries, and Risk Factors Study 2021 data set, encompassing data from 204 countries and territories. EOPC was defined as PC diagnosed in individuals age 15-49 years. Statistical analyses and visualizations were performed using R (version 4.3.2) and Python (version 3.11). RESULTS: Globally, EOPC incident cases increased 1.63-fold from 19,366 in 1990 to 31,531 in 2021. Mortality rose by 57% during the same period, with a total of 26,996 deaths in 2021. Age-standardized incidence and mortality rates declined slightly, reflecting demographic changes and population growth. Middle Sociodemographic Index (SDI) regions exhibited the most rapid increases in both cases and deaths. In 2021, smoking accounted for 8.1% of EOPC deaths, whereas high fasting plasma glucose and high BMI contributed to 6.3% and 5.7% of deaths, respectively. Projections indicate a 10.6% global increase in EOPC cases and deaths by 2040, with the largest absolute increases expected in low-middle SDI regions. CONCLUSION: EOPC incidence and mortality are rising globally, with middle and low-middle SDI regions facing the most rapid increases and projected to carry the greatest burden by 2040. These findings emphasize the need for primary prevention, access to diagnostics, and equitable health care systems. Addressing modifiable risk factors, such as smoking and metabolic syndrome, will be critical in reducing the overall impact of EOPC.

18 June 2026
Verified
Other
Open access
LLLuís Felipe Leite
Luís Felipe Leite
LCLucas Diniz da Conceição
Lucas Diniz da Conceição
ESErick F. Saldanha
Erick F. Saldanha
SMSamuel Menezes
Samuel Menezes
AMAndreia C. De Melo
Andreia C. De Melo
VLVLADMIR Cláudio CORDEIRO DE LIMA
VLADMIR Cláudio CORDEIRO DE LIMA
Estimated incident cancer cases and deaths for 2022 and projected values for 2050, stratified by country and sex across all ages.

18 June 2026
Verified
Other
Open access
LLLuís Felipe Leite
Luís Felipe Leite
LCLucas Diniz da Conceição
Lucas Diniz da Conceição
ESErick F. Saldanha
Erick F. Saldanha
SMSamuel Menezes
Samuel Menezes
AMAndreia C. De Melo
Andreia C. De Melo
VLVLADMIR Cláudio CORDEIRO DE LIMA
VLADMIR Cláudio CORDEIRO DE LIMA
Cancer types by ASIR and ASMR in 2022 across all age groups. A, Bar plot of ASIR stratified by sex and cancer type. B, Sex-stratified maps of LAC showing the most common incidence sites by country. C, Bar plot of ASMR stratified by sex and cancer type. D, Sex-stratified maps of LAC showing the most common mortality sites by country.

18 June 2026
Verified
Other
Open access
LLLuís Felipe Leite
Luís Felipe Leite
LCLucas Diniz da Conceição
Lucas Diniz da Conceição
ESErick F. Saldanha
Erick F. Saldanha
SMSamuel Menezes
Samuel Menezes
AMAndreia C. De Melo
Andreia C. De Melo
VLVLADMIR Cláudio CORDEIRO DE LIMA
VLADMIR Cláudio CORDEIRO DE LIMA
Figure S7. Projected cases and deaths numbers (per 1,000 persons) under varying global rate-change scenarios, 2022–2050.